benefit of two of the newer drugs for osteoporosis

There's good news about the benefit of two of the newer drugs for osteoporosis...Evista (raloxifene) and Fosamax (alendronate).

Evista has now been shown to prevent FRACTURES...initially it was shown just to increase bone density.

Evista cuts the risk of spinal fractures in postmenopausal women who take it for two years. There's no info yet on whether Evista reduces hip fractures.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber's Letter includes:

  • 12 issues every year, with brief articles about new meds and guidelines
  • 48+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote